5-Bromothiophene-3-carboxylic acid → HCID 71252690, compound
Reaction equation
[Br:1][C:2]1[S:6][CH:5]=[C:4]([C:7]([OH:9])=O)[CH:3]=1.[CH3:10][C:11]1[C:12]([N:18]2[CH2:23][CH2:22][NH:21][CH2:20][CH2:19]2)=[N:13][CH:14]=[C:15]([CH3:17])[CH:16]=1>>[Br:1][C:2]1[S:6][CH:5]=[C:4]([C:7]([N:21]2[CH2:22][CH2:23][N:18]([C:12]3[C:11]([CH3:10])=[CH:16][C:15]([CH3:17])=[CH:14][N:13]=3)[CH2:19][CH2:20]2)=[O:9])[CH:3]=1Participants
3
Procedure
Using 5-bromothiophene-3-carboxylic acid (500 mg) and 1-(3,5-dimethylpyridin-2-yl)piperazine (462 mg) described in Preparation Example 79 and by the reaction and treatment in the same manner as in Preparation Example 118, the title compound (700 mg) was obtained.
Workup
- customdescribed in Preparation Example 79 and by the reaction and treatment in the same manner as in Preparation Example 118
Sources & evidence
- ORD record
- ord-5214d9748300452fb47c2cfa6ea70dd0
- Source dataset
- uspto-grants-2014_08
- Patent number
- US08816079B2
Reaction notes
Loading…